1. Home
  2. TXMD vs IRIX Comparison

TXMD vs IRIX Comparison

Compare TXMD & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.18

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.99

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXMD
IRIX
Founded
2008
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
23.2M
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
TXMD
IRIX
Price
$2.18
$0.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.6K
48.7K
Earning Date
05-12-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
80.61
8.47
EPS
N/A
N/A
Revenue
$1,761,000.00
$41,593,000.00
Revenue This Year
$427.09
$10.43
Revenue Next Year
N/A
$7.32
P/E Ratio
$90.64
N/A
Revenue Growth
35.25
N/A
52 Week Low
$0.84
$0.79
52 Week High
$2.95
$1.65

Technical Indicators

Market Signals
Indicator
TXMD
IRIX
Relative Strength Index (RSI) 37.04 23.19
Support Level $1.05 $0.87
Resistance Level $2.35 $1.22
Average True Range (ATR) 0.11 0.07
MACD -0.02 -0.03
Stochastic Oscillator 2.67 8.43

Price Performance

Historical Comparison
TXMD
IRIX

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: